Epsilon Healthcare Limited

EPN

AU0000137598

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 05:07:33 18/12/2023 am IST			5-day change	1st Jan Change
0.024 ^AUD	-.--%		-.--%	-.--%

2023	Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	CI
2023	Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	CI

Epsilon Healthcare Limited Announces Change of Registered Office and Principal Place of Business

November 30, 2022 at 12:16 pm IST

Epsilon Healthcare Limited advised that its registered office and principal place of business has changed with effect from November 30, 2022 to the following: Epsilon Healthcare Limited: Level 17; 9 Castlereagh Street; Sydney NSW 2000.

Latest news about Epsilon Healthcare Limited

Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	20/12	CI
Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	20/12	CI
Epsilon Healthcare Appoints Joint and Several Administrators	18/12	MT
Epsilon Healthcare Limited Provides Information to Shareholders	15/12	CI
Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd	01/12	CI
Epsilon Healthcare Limited Announces Board Appointments	01/12	CI
Epsilon Healthcare Provides Information to Shareholders	22/11	CI
Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer	21/11	CI
Epsilon Healthcare Issues Notice of Extraordinary General Meeting	21/11	CI
Epsilon Healthcare Limited Announces Change of Address, Effective 22 November 2023	21/11	CI
Epsilon Healthcare Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Epsilon Healthcare Rebrands Manufacturing, Telehealth Businesses	03/23/03	MT
Epsilon Healthcare Appoints CEO	19/23/19	MT
Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023	19/23/19	CI
Healthcare, IT Rally Ends Australian Shares' Three-Day Losing Streak	12/23/12	MT
Epsilon Healthcare Jumps 25% After Subsidiary Renews Medicinal Cannabis Permit	12/23/12	MT
Epsilon Healthcare Limited Auditor Raises 'Going Concern' Doubt	31/23/31	CI
Epsilon Healthcare Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Epsilon Healthcare Limited Announces Executive Changes	23/22/23	CI
Epsilon Healthcare Limited Announces Company Secretary Changes	30/22/30	CI
Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer	30/22/30	CI
Epsilon Healthcare Limited Announces Change of Registered Office and Principal Place of Business	30/22/30	CI
Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director	04/22/04	CI
Epsilon Healthcare Limited Announces Board Changes	01/22/01	CI
Epsilon Healthcare Limited Announces Appointment of Josh Cui as Director	31/22/31	CI

Chart Epsilon Healthcare Limited

Duration

Period

More charts

Company Profile

Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Companyâs segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Companyâs subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.

Sector

Pharmaceuticals

Calendar

29/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EPSILON HEALTHCARE LIMITED	-.--%	4.76M
ELI LILLY AND COMPANY	+52.28%	797B
NOVO NORDISK A/S	+40.80%	628B
JOHNSON & JOHNSON	-6.86%	351B
MERCK & CO., INC.	+17.82%	323B
ABBVIE INC.	+11.12%	300B
ASTRAZENECA PLC	+17.17%	244B
ROCHE HOLDING AG	+0.94%	223B
AMGEN INC.	+5.35%	163B
PFIZER, INC.	-5.02%	153B